Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05962710 · ClinicalTrials.gov registry record
FreeStyle Libre 3 Continuous Glucose Monitoring System
A clinical trial, sponsored by Abbott Diabetes Care.
- Terminated
- Registry status
- 7
- Enrollment target
NCT05962710 is a clinical trial that was terminated before completion, run by Abbott Diabetes Care. The registered enrollment target is 7 participants.
The verdict
NCT05962710 was terminated before completion, sponsored by Abbott Diabetes Care.
- TERMINATED
- Registry status
- 7 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize the FreeStyle Libre 3 Continuous Glucose Monitoring System performance with respect to YSI reference venous plasma sample measurements.
Interventions
- DEVICE FreeStyle Libre 3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2023-01-27 |
| Est. Completion | 2023-01-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05962710
The ClinicalTrials.gov registry entry for NCT05962710 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Diabetes Care, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FreeStyle Libre 3 is the first listed.
NCT05962710 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05962710 about?
NCT05962710 is a clinical study titled "FreeStyle Libre 3 Continuous Glucose Monitoring System". The purpose of this study is to characterize the FreeStyle Libre 3 Continuous Glucose Monitoring System performance with respect to YSI reference venous plasma sample measurements.
What is the current status of trial NCT05962710?
This trial is currently terminated. The enrollment target is 7 participants. The study started on 2023-01-27. Estimated completion is 2023-01-31.
What interventions are being tested in trial NCT05962710?
The interventions under investigation include: FreeStyle Libre 3 (DEVICE).
Who is sponsoring clinical trial NCT05962710?
This trial is sponsored by Abbott Diabetes Care, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.